Zobrazeno 1 - 10
of 38
pro vyhledávání: '"Justin S. Waters"'
Autor:
William R. C. Knight, Justin S. Waters, William H. Allum, R Bott, J Zylstra, David Cunningham, Nick Maisey, Michelle J. Wilkinson, Jesper Lagergren, James A. Gossage, Mark Kelly, Kerri Beckmann, Cara R. Baker, Elizabeth C Smyth, Andrew Davies, Mieke Van Hemelrijck
Publikováno v:
Acta Oncologica. 60:672-680
Background: The role of adjuvant therapy in patients with oesophagogastric adenocarcinoma treated by neoadjuvant chemotherapy (NAC) and surgery is contentious. In UK practice, surgical resection margin status is often used to classify patients into r
Autor:
Sharmila Sothi, S. P. Stenning, J. T. Dent, D Alderson, William H. Allum, David Cunningham, Ruth E Langley, Helen Neville-Webbe, Jane M Blazeby, Fay H. Cafferty, Andrew Wotherspoon, Matthew T. Seymour, Tom Crosby, Elizabeth C Smyth, Justin S. Waters, Was Mansoor, S Rowley, Heike I. Grabsch, Suzanne Darby, Joyce Thompson
Publikováno v:
Smyth, E C, Rowley, S, Cafferty, F H, Allum, W H, Grabsch, H I, Stenning, S, Wotherspoon, A, Alderson, D, Crosby, T, Mansoor, W, Waters, JS, Neville-Webb, H, Darby, S, Dent, J, Seymour, M, Thompson, J, Sothi, S, Blazeby, J, Langley, RE & Cunningham, D 2019, ' Safety and Efficacy of the Addition of Lapatinib to Perioperative Chemotherapy for Resectable HER2-Positive Gastroesophageal Adenocarcinoma : A Randomized Phase 2 Clinical Trial ', JAMA Oncology . https://doi.org/10.1001/jamaoncol.2019.1179
JAMA Oncology, 5(8), 1181-1187. American Medical Association
JAMA Oncology, 5(8), 1181-1187. American Medical Association
Importance Perioperative chemotherapy and surgery are a standard of care for operable gastroesophageal adenocarcinoma. Anti-HER2 therapy improves survival in patients with advanced HER2-positive disease. The safety and feasibility of adding lapatinib
Autor:
John Bridgewater, Stephen Falk, Kinnari Patel, Alan Anthoney, Harpreet Wasan, W David J Ryder, Safia Barber, Juan W. Valle, Daniel H. Palmer, Yuk Ting Ma, Roopinder Gillmore, Arvind Arora, Jonathan Wadsley, John Ramage, Angela Lamarca, Claire Hobbs, Timothy Iveson, Justin S. Waters, Linda Davies, Paul Ross, Anthony Maraveyas
Publikováno v:
The Lancet Oncology. 22:e288-e289
Autor:
Pei Loo Ow, Angel Garcia, Lesley Samuel, Rajarshi Roy, Adam McGeoch, D. Fyfe, W Saku, Simon Aird Grumett, Jonathan Nicoll, Jo Dent, Tom Samuel Waddell, Jo Webster, Christine Allmark, Tania Tillett, Colin Askill, Justin S. Waters, C. Handforth, Erica Beaumont, Vallipuram Vigneswaran, Sharon Ruddock, Nick Wadd, Syed Zubair, Kinnari Patel, Vanessa Potter, Daniel Propper, Olwyn Williams, Marc Jones, Kamalnayan Guptal, Peter Hall, Gareth Griffiths, Joseph Mano, Juan W. Valle, Sheela Rao, David A Cairns, Go Trial Investigators, Eszter Katona, Nick Maisey, Chris Twelves, Daniel Swinson, Nicholas Reed, Heike I. Grabsch, Joanne Askey, Jonathan Wadsley, Tom Roques, Sue Cheeseman, Stephen Falk, Louise Medley, Arshad Jamil, Emma Cattell, Victori Kunene, Matthew R. Sydes, Charles Candish, Claire Hobbs, Rebecca Herbertson, Jo Parkinson, Nicholas S. Reed, Louise Brook, Zuzana Stokes, Mohammed Khan, Ann Crossley, Elin Jones, George Bozas, Sebastian Cummins, Anirban Chatterjee, Michael Bennet, Helen Marshall, Pavel Bezecny, David Sherriff, Matthew T. Seymour, Lauren Gorf, Galina Velikova, Jean Gall, Kamposioras Konstantinos-Velios, Sally Clive, Eleanor James, Fiona Collinson, Dunca Wilkins, Simon Lord, Julia Brown, Serena Hilman, A. Robinson, Richard Ellis, Alaaeldin Shablak, Russell D Petty, Sherif Raouf, Helen Howard
Publikováno v:
Hall, P S, Swinson, D, A. Cairns, D, S. Waters, J, Petty, R, Allmark, C, Ruddock, S, Falk, S, Wadsley, J, Roy, R, Tillett, T, Nicoll, J, Cummins, S, Mano, J, Grumett, S, Stokes, Z, Konstantinos-Velios, K, Chatterjee, A, Garcia, A, Waddell, T, Guptal, K, Maisey, N, Khan, M, Dent, J, Lord, S, Crossley, A, Katona, E, Marshall, H, I. Grabsch, H, Velikova, G, Loo Ow, P, Handforth, C, Howard, H & T. Seymour, M 2021, ' Efficacy of Reduced-Intensity Chemotherapy With Oxaliplatin and Capecitabine on Quality of Life and Cancer Control Among Older and Frail Patients With Advanced Gastroesophageal CancerThe GO2 Phase 3 Randomized Clinical Trial ', JAMA Oncology . https://doi.org/10.1001/jamaoncol.2021.0848
JAMA Oncology, 7(6), 869-877. American Medical Association
JAMA Oncology, 7(6), 869-877. American Medical Association
Importance: Older and/or frail patients are underrepresented in landmark cancer trials. Tailored research is needed to address this evidence gap. Objective: The GO2 randomized clinical trial sought to optimize chemotherapy dosing in older and/or frai
Autor:
Justin S Waters, David Cunningham
Publikováno v:
Drug Therapy for Gastrointestinal and Liver Diseases ISBN: 9780429265433
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::dbf7fc0552d90738263449b96e574928
https://doi.org/10.1201/9780429265433-9
https://doi.org/10.1201/9780429265433-9
Autor:
Alan Anthoney, Juan W. Valle, G Young, Katherine Anne Sumpter, N Begum, R Hardy, David Cunningham, Pippa Corrie, N Sarwar, Denis Talbot, Tim Meyer, Paul Ross, Lucy Wall, N. Reed, Wendi Qian, Tom Crosby, Justin S. Waters
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7d1c3b007572318c8767471e8e2a4f5d
https://doi.org/10.1093/annonc/mdw369.31
https://doi.org/10.1093/annonc/mdw369.31
Autor:
Rajarshi Roy, Tania Tillett, Galina Velikova, Matthew T. Seymour, Simon Aird Grumett, Peter Hall, Helen Marshall, Angel Garcia, Jonathan Nicoll, Jonathan Wadsley, Sharon Ruddock, Christine Allmark, Daniel Swinson, Stephen Falk, Justin S. Waters, Russell D. Petty, Heike I. Grabsch, Eszter Katona, Sebastian Cummings, Konstantinos Kamposioras
Publikováno v:
Journal of Clinical Oncology. 37:4006-4006
4006 Background: Many pts with aGOAC are elderly and/or frail. We previously compared epirubin/ oxaliplatin/ capecitabine (EOCap) vs OCap vs Cap in a pick-the-winner study and found OCap best. GO2 was designed to find the optimum dose of OCap and to
Autor:
Arvind Arora, Stephen Falk, Jonathan Wadsley, Juan W. Valle, Anthony Maraveyas, Claire Hobbs, Angela Lamarca, Yuk Ting Ma, Harpreet Wasan, Paul Ross, Safia Barber, David Ryder, Alan Anthoney, Kinnari Patel, Daniel H. Palmer, Justin S. Waters, John Bridgewater, Roopinder Gillmore, Linda Davies, John Ramage
Publikováno v:
Journal of Clinical Oncology. 37:4003-4003
4003 Background: Level A evidence supports use of CisGem as first-line chemotherapy for ABC; no robust evidence is available for second-line chemotherapy. Methods: Pts diagnosed with ABC with disease progression after prior CisGem were randomised (1:
Autor:
Daniel Catovsky, Matthew C.H. Ng, A C Wotherspoon, David Cunningham, Mark A. Hill, Alan Horwich, Ian Chau, A. R. Norman, Justin S. Waters
Publikováno v:
British Journal of Cancer
There is currently no standard salvage chemotherapy regimen in relapsed and refractory lymphoma. Gemcitabine is a novel nucleoside analogue, which acts synergistically with cisplatin both in vitro and in clinical studies. We evaluated the combination
Autor:
Roger A'Hern, Tim Eisen, M. G. James, S Hackett, Justin S. Waters, Martin Gore, C Moss, Lynda Pyle
Publikováno v:
British Journal of Cancer
We report a single institution phase II study of gemcitabine 1200 mg m(-2) i.v. on days 1 and 8 and capecitabine 1300 mg m(-2) twice daily on days 1-14 of each 3-week cycle in patients with metastatic renal carcinoma. Patients had a WHO performance s